B cell depletion therapy in systemic lup
✍
G. Cambridge; M. J. Leandro; M. Teodorescu; J. Manson; A. Rahman; D. A. Isenberg
📂
Article
📅
2006
🏛
John Wiley and Sons
🌐
English
⚖ 699 KB
## Abstract ## Objective Autoantibody production in patients with systemic lupus erythematosus (SLE) is associated with abnormalities of B cell function and phenotype. Clinical responses to B cell depletion therapy (BCDT), based on rituximab, are encouraging. Therefore, we undertook this study to